JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

$0.24
-0.01 (-4.74%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +18,128.2% upside
Low Target $31.75
Average Target $43.93
High Target $69.04
Current Price $0.24
Current
$0.24
Target
$43.93
$31.75 $43.93 avg $69.04
Scenario Analysis
Bear Case
$31.75
13,074.3%
Low target
Base Case
$43.93
+18,128.2%
Avg target
Bull Case
$69.04
+28,547.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.33
-92.8% from high
52-Week Low
$0.17
+40.0% from low
Target vs 52W High
$43.93
+1,219.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%